Jake Xia
Directeur/Bestuurslid bij Hangzhou Qihan Biotech Co., Ltd.
Actieve functies van Jake Xia
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Hangzhou Qihan Biotech Co., Ltd.
 Hangzhou Qihan Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Hangzhou Qihan Biotech Co., Ltd. is a biotech company that applies genome-editing technology to develop novel cell therapies and organs for transplantation. The company is based in Hangzhou, China. The Chinese company's mission is to create immunologically privileged allogeneic cells and xenogeneic organs for use as therapies to treat cancer, organ failure, and other complex medical conditions. Qihan Biotech has raised two rounds of financing and is advancing its cell therapy programs into IND enabling investigations. It was founded in 2017 by Luhan Yang and George McDonald Church, with Luhan Yang serving as the CEO since then. | Directeur/Bestuurslid | - | - |
Loopbaan van Jake Xia
Eerdere bekende functies van Jake Xia
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Salomon Brothers | Corporate Officer/Principal | - | - |
Morgan Stanley Capital Partners (Private Equity)
 Morgan Stanley Capital Partners (Private Equity) Investment ManagersFinance Morgan Stanley Capital Partners (Morgan Stanley Capital) is a private equity subsidiary of Morgan Stanley founded in 1985. The firm is headquartered in New York. | Corporate Officer/Principal | - | - |
Opleiding van Jake Xia
| Massachusetts Institute of Technology | Doctorate Degree |
| Northeastern University | Graduate Degree |
| Peking University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
| China | 3 |
Operationeel
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Sectoraal
| Finance | 4 |
| Consumer Services | 3 |
| Health Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Morgan Stanley Capital Partners (Private Equity)
Morgan Stanley Capital Partners (Private Equity) Investment ManagersFinance Morgan Stanley Capital Partners (Morgan Stanley Capital) is a private equity subsidiary of Morgan Stanley founded in 1985. The firm is headquartered in New York. | Finance |
| Salomon Brothers | Finance |
Hangzhou Qihan Biotech Co., Ltd.
Hangzhou Qihan Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Hangzhou Qihan Biotech Co., Ltd. is a biotech company that applies genome-editing technology to develop novel cell therapies and organs for transplantation. The company is based in Hangzhou, China. The Chinese company's mission is to create immunologically privileged allogeneic cells and xenogeneic organs for use as therapies to treat cancer, organ failure, and other complex medical conditions. Qihan Biotech has raised two rounds of financing and is advancing its cell therapy programs into IND enabling investigations. It was founded in 2017 by Luhan Yang and George McDonald Church, with Luhan Yang serving as the CEO since then. | Health Services |
